Product information and disease descriptionProduct descriptionProduct information
Indication
5 evidence topics · 5 sources
Metastatic castration-resistant prostate cancer previously treated with abiraterone, in combination with darolutamide
Product information and disease descriptionProduct descriptionProduct information
5 evidence topics · 5 sources